OncoCyte Corp.
(NYSE Amex Equities : OCX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
ABTAbbott Laboratories
3.17%70.880.8%$495.89m
MDTMedtronic PLC
2.67%96.320.6%$456.48m
ISRGIntuitive Surgical, Inc.
3.38%536.822.4%$388.78m
TMOThermo Fisher Scientific Inc.
2.98%234.891.0%$336.30m
EWEdwards Lifesciences Corporation
3.20%146.331.2%$307.25m
ALGNAlign Technology, Inc.
3.55%328.716.3%$295.26m
ABMDABIOMED, Inc.
2.37%380.893.3%$284.94m
BSXBoston Scientific Corporation
4.34%38.011.1%$267.70m
BDXBecton, Dickinson and Company
1.59%242.091.1%$229.26m
SYKStryker Corporation
3.06%174.591.3%$228.68m
BAXBaxter International Inc.
0.73%71.391.7%$194.67m
DXCMDexCom, Inc.
5.42%131.958.5%$173.19m
TNDMTandem Diabetes Care, Inc.
6.25%38.544.1%$171.23m
ZBHZimmer Biomet Holdings, Inc.
2.15%126.151.7%$123.31m
INGNInogen, Inc.
4.96%211.696.1%$111.86m

Company Profile

OncoCyte Corp. is a pharmaceutical company. It is focused on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company was founded in September 2009 and is headquartered in Alameda, CA.